Global Biotechnological Drugs Market Growth (Status and Outlook) 2023-2029

Global Biotechnological Drugs Market Growth (Status and Outlook) 2023-2029

LPI (LP Information)' newest research report, the “Biotechnological Drugs Industry Forecast” looks at past sales and reviews total world Biotechnological Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Biotechnological Drugs sales for 2023 through 2029. With Biotechnological Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biotechnological Drugs industry.

This Insight Report provides a comprehensive analysis of the global Biotechnological Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Biotechnological Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biotechnological Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biotechnological Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biotechnological Drugs.

The global Biotechnological Drugs market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Biotechnological Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Biotechnological Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Biotechnological Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Biotechnological Drugs players cover 3SBIO, Anhui Anke Biotechnology, Beijing SL Pharmaceutical, Biotech Pharmaceutical, Cadila Healthcare, Celgen Biopharma, Celltrion, Dr Reddy’s and GeneScience Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Biotechnological Drugs market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Genetically Engineered Drugs
Therapeutic Monoclonal Antibody Drugs
Gene Therapy and Nucleic Acid Drugs
Genetically Engineered Vaccines
Other

Segmentation by application
Tumor
Autoimmune Disease
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
3SBIO
Anhui Anke Biotechnology
Beijing SL Pharmaceutical
Biotech Pharmaceutical
Cadila Healthcare
Celgen Biopharma
Celltrion
Dr Reddy’s
GeneScience Pharmaceuticals
Hisun Pharma
Jiangsu Sihuan Bioengineering
Novartis (Sandoz)
Pfizer (Hospira)
Shanghai Lansheng Guojian Pharmaceutical
Shenzhen Neptunus Interlong Bio-Technique
Tonghua Dongbao Pharmaceutical
Torrent Pharmaceuticals

Please note: The report will take approximately 2 business days to prepare and deliver.